Henry Schein Profile

75.23
USD 0.74  0.99%
100%
69%

Sale by Stanley Bergman of 100 shares of Henry Schein

Henry Schein insider trading alert for sale of common stock par value $0.01 by Stanley Bergman, Chairman CEO, on April 23, 2018. This event was filed by Henry Schein Inc with SEC on 2006-03-27. Statement of changes in beneficial ownership - SEC Form 4 [view details]   

Henry Schein Summary

Henry Schein (HSIC) is traded on NASDAQ in USA. It is located in NEW YORK, U.S.A and employs 22,000 people. Henry Schein is listed under Wholesale category by Fama And French industry classification.The company currently falls under 'Large-Cap' category with current market capitalization of 11.39 B. Henry Schein conducts business under Healthcare sector and is part of Healthcare Products industry. This company has 154.31 M outstanding shares of which 10.83 M shares are currently shorted by private and institutional investors with about 4.01 trading days to cover. HENRY SCHEIN INC currently holds about 174.66 M in cash with 545.52 M of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.14.
Check Henry Schein Probability Of Bankruptcy

Ownership Allocation (%)

Target Price Odds Analysis

Below OddsHorizonTargetAbove Odds
close to 99%30 days 75.23  near 1%
Based on normal probability distribution, the odds of Henry Schein to move above current price in 30 days from now is near 1% (This Henry Schein probability density function shows the probability of Henry Schein Stock to fall within a particular range of prices over 30 days) .

Top Holders

Major Institutional Holders

InstituionSecurity TypeTotal SharesValue
Longview Partners Guernsey LtdCommon Shares13.9 M933.4 M
Fisher Asset Management LlcCommon Shares1 M67.5 M
View Henry Schein Diagnostics

Selected Henry Schein Income Statement Over Time

Consolidated Income    Earning Before Interest and Taxes EBIT    Net Income    

Key Fundamentals

Henry Schein Against Markets

Risk Adjusted
Performance Score (0 to 100)
8 
Chance of
Financial Distress (0 to 100%)
< 1% 
Equity ratings for Henry Schein are calculated dynamically based on Macroaxis scoring framework. Click here to learn more
Henry Schein, Inc. provides health care products and services to dental practitioners and laboratories, animal health clinics, physician practices, government, institutional health care clinics, and other alternate care clinics worldwide. The company was founded in 1932 and is headquartered in Melville, New York. Henry Schein operates under Medical Distribution classification in USA and traded on NASDAQ. It employs 22000 people. more
Fama & French Wholesale
Wholesale
Fama & French Classification
NameHenry Schein
CEOLonnie ShoffView All
Thematic Classifications
Active Investing Ideas
showing 2 out of 3 themes  View All
Analyst Consensus
Piotroski F Score
Macroaxis Advice
Specialization
Healthcare, Healthcare Products
InstrumentUSA Stock View All
RegionNorth America
LocationNEW YORK, U.S.A
Business Address135 Duryea Road
Foreign Associates
ExchangeNASDAQ
CIK Number01000228.0
ISINUS8064071025
CUSIP806407102
SectorHealthcare
IndustryHealthcare Products
BenchmarkDOW
Websitewww.henryschein.com
Contact Number631 843 5500
CurrencyUSD - US Dollar

Current Sentiment - HSIC

Henry Schein Investor Sentiment
Most of Macroaxis users are currently bullish on Henry Schein. What is your judgment towards investing in Henry Schein? Are you bullish or bearish?
Bullish
Bearish
98% Bullish
2% Bearish
Skip

Recommendations

Henry Schein Analyst Recommendations
Target PriceAdvice# of Analysts
177.14Buy7Odds
Henry Schein current and past analyst recommendations published by number of research institutions as well as average analyst consensus
Henry Schein Analyst Advice  

Earnings

Henry Schein Earnings Estimates
EPSEstimate Date
Quarterly Estimate1.66May 2, 2017
Henry Schein normalized analysts earnings estimates for actual as well as projected forward EPS values taken as an average expert opinion over time
Earnings Estimate  

Directors

Henry Schein Corporate Directors
Norman Matthews Independent Director
Philip Laskawy Lead Independent Director
Steven Paladino CFO, Executive VP and Executive Director
Please also check Risk vs Return Analysis. Please also try Equity Valuation module to check real value of public entities based on technical and fundamental data.